VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MDPediatrix Medical Group, Inc.
$24.69$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMDQuarterly Financials

Pediatrix Medical Group, Inc. (MD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Pediatrix Medical Group, Inc. (MD) quarterly income statement — complete revenue, gross profit & net income history

MD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue476.2M493.77M492.88M468.84M458.36M502.36M511.16M504.3M495.1M496.44M506.61M500.58M491.01M513.84M489.92M486.03M482.23M498.53M492.95M472.96M
Revenue Growth %3.89%-1.71%-3.58%-7.03%-7.42%1.19%0.9%0.74%0.83%-3.39%3.41%2.99%1.82%3.07%-0.62%2.76%7.94%19.66%7.02%13.84%
Cost of Goods Sold369.35M373.42M352.53M344.12M355.72M373.84M394.34M390.18M400.22M395.28M399.72M385.12M392.95M398.04M374.71M360.6M371.64M360.63M354.88M341.22M
COGS % of Revenue77.56%75.63%71.52%73.4%77.61%74.42%77.15%77.37%80.84%79.62%78.9%76.94%80.03%77.46%76.48%74.19%77.07%72.34%71.99%72.15%
Gross Profit106.84M120.35M140.35M124.73M102.64M128.53M116.82M114.12M94.88M101.17M106.89M115.46M98.05M115.81M115.21M125.43M110.58M137.9M138.07M131.74M
Gross Margin %22.44%24.37%28.48%26.6%22.39%25.58%22.85%22.63%19.16%20.38%21.1%23.06%19.97%22.54%23.52%25.81%22.93%27.66%28.01%27.85%
Gross Profit Growth %4.09%-6.36%20.14%9.3%8.18%27.04%9.29%-1.16%-3.24%-12.64%-7.22%-7.95%-11.33%-16.02%-16.56%-4.79%4.79%28.14%7.62%17.33%
Operating Expenses60.27M65.68M72.3M64.86M70.54M89.23M82.99M271.84M78.99M212.66M66.62M66.96M68.01M79.77M67.82M75.28M71.48M69.9M79.28M81.73M
OpEx % of Revenue12.66%13.3%14.67%13.83%15.39%17.76%16.24%53.91%15.95%42.84%13.15%13.38%13.85%15.52%13.84%15.49%14.82%14.02%16.08%17.28%
Selling, General & Admin60.27M65.68M60.79M55.71M58.6M63.55M58.12M56.56M60.2M53.06M57.41M58.01M59.06M51.06M57.89M61.16M61.29M58.98M66.89M70.97M
SG&A % of Revenue12.66%13.3%12.33%11.88%12.79%12.65%11.37%11.22%12.16%10.69%11.33%11.59%12.03%9.94%11.82%12.58%12.71%11.83%13.57%15.01%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income46.58M54.67M68.05M59.87M32.1M39.29M33.83M-157.72M15.89M-111.49M40.27M48.5M30.04M36.04M47.39M50.16M39.11M68M58.79M50.02M
Operating Margin %9.78%11.07%13.81%12.77%7%7.82%6.62%-31.28%3.21%-22.46%7.95%9.69%6.12%7.01%9.67%10.32%8.11%13.64%11.93%10.58%
Operating Income Growth %45.1%39.15%101.17%137.96%101.99%135.24%-16%-425.22%-47.1%-409.37%-15.01%-3.3%-23.18%-47.01%-19.4%0.28%49.82%110.51%187.37%44.7%
EBITDA52.7M60.3M73.6M65.18M37.43M46.16M40.08M-148.93M26.2M-102.43M49.48M57.44M38.99M45.17M56.34M58.93M47.88M75.86M66.94M58.12M
EBITDA Margin %11.07%12.21%14.93%13.9%8.17%9.19%7.84%-29.53%5.29%-20.63%9.77%11.48%7.94%8.79%11.5%12.12%9.93%15.22%13.58%12.29%
EBITDA Growth %40.78%30.63%83.63%143.76%42.87%145.07%-19%-359.27%-32.81%-326.74%-12.18%-2.52%-18.55%-40.45%-15.84%1.39%40.26%89.67%142.08%40.68%
D&A (Non-Cash Add-back)6.12M5.63M5.55M5.31M5.33M6.87M6.25M8.79M10.31M9.06M9.21M8.95M8.95M9.14M8.96M8.78M8.77M7.86M8.15M8.11M
EBIT46.58M54.34M90.84M64.1M37.24M43.04M35.36M-157.42M18.42M-128.77M41.21M48.5M30.04M37.78M48.38M51.44M-16.53M70.12M61.03M54.77M
Net Interest Income-3.5M-4.04M-3.06M-9.13M-9.15M-9.71M-10.13M-10.31M-10.6M-10.08M-10.37M-11.23M-10.39M-9.95M-9.52M-8.41M-11.82M-16.6M-17.59M-16.88M
Interest Income04.7M000000000000000000
Interest Expense-8.27M8.74M3.06M9.13M9.15M9.71M10.13M10.31M10.6M10.08M10.37M11.23M10.39M9.95M9.52M8.41M11.82M16.6M17.59M16.88M
Other Income/Expense-7.74M-9.08M19.73M-4.9M-4.01M-5.96M-8.59M-10.01M-8.07M-27.36M-9.44M-9.55M-9.33M-8.21M-8.53M-7.12M-67.45M-14.49M-15.36M-12.13M
Pretax Income38.84M45.59M87.78M54.97M28.09M33.33M25.23M-167.73M7.82M-138.85M30.83M38.95M20.71M27.82M38.86M43.03M-28.35M53.52M43.43M37.89M
Pretax Margin %8.16%9.23%17.81%11.72%6.13%6.63%4.94%-33.26%1.58%-27.97%6.09%7.78%4.22%5.41%7.93%8.85%-5.88%10.73%8.81%8.01%
Income Tax-9.27M11.91M16.07M15.71M7.35M2.85M5.79M-14.7M3.79M-14.56M9.44M10.66M6.51M3.82M10.05M12.33M-7.4M13.24M11.59M7.36M
Effective Tax Rate %-23.87%26.13%18.31%28.58%26.18%8.55%22.96%8.77%48.43%10.49%30.62%27.38%31.41%13.74%25.87%28.66%26.11%24.74%26.69%19.43%
Net Income29.57M33.68M71.71M39.26M20.74M30.48M19.44M-153.03M4.04M-124.29M21.39M28.28M14.21M29.66M30.73M27.14M-21.19M47.52M30.8M35.01M
Net Margin %6.21%6.82%14.55%8.37%4.52%6.07%3.8%-30.34%0.81%-25.04%4.22%5.65%2.89%5.77%6.27%5.58%-4.39%9.53%6.25%7.4%
Net Income Growth %42.6%10.51%268.85%125.66%413.93%124.52%-9.12%-641.07%-71.6%-519.05%-30.39%4.22%167.05%-37.58%-0.22%-22.49%-220.1%173.9%175.03%105.21%
Net Income (Continuing)29.57M33.68M71.71M39.26M20.74M30.48M19.44M-153.03M4.04M-124.29M21.39M28.28M14.21M24M28.81M30.7M-20.95M40.28M31.84M30.53M
Discontinued Operations00000000000001000K1000K-1000K-247K1000K-1000K1000K
Minority Interest00000000000000000205K211K218K
EPS (Diluted)0.360.400.840.450.240.350.23-1.840.05-1.500.260.340.170.360.370.32-0.250.550.360.41
EPS Growth %50%14.29%265.22%124.46%380%123.33%-11.54%-641.18%-70.59%-516.67%-29.73%6.25%168%-34.55%2.78%-21.95%-219.05%172.37%173.47%105.09%
EPS (Basic)0.360.400.850.450.240.350.23-1.840.05-1.480.260.340.170.360.370.32-0.250.550.360.41
Diluted Shares Outstanding83.08M84.42M85.61M86.85M85.81M85.87M84.52M83.33M83.28M84.02M82.95M82.66M82.32M82.95M82.78M85.62M85.41M86.42M86.1M85.93M
Basic Shares Outstanding83.08M84.42M85.37M86.85M85.81M85.87M83.89M83.33M82.86M84.02M82.54M82.4M81.89M82.95M82.13M84.06M85.41M86.42M85.06M84.91M
Dividend Payout Ratio--------------------